D-0117-2018 Class II Terminated
FDA drug recall D-0117-2018 was initiated by Advanced Pharma Inc. on Jun 9, 2017 and is designated Class II. Reason for recall: Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system. The recall status is terminated (terminated Apr 3, 2019). Affected quantity: 50 syringes.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 27, 2017
- Initiation Date
- Jun 9, 2017
- Termination Date
- Apr 3, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 50 syringes
Product description
NitroGlycerin 100 mcg/mL QS 5% Dextrose Inj, USP (2 mg per 20 mL) 20 mL Sterile single dose syringe, packaged in 10 x 5 (FIFTY) syringes per box, Rx only, Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054, NDC 15082-818-62.
Reason for recall
Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.
Distribution pattern
Nationwide in the USA to hospitals and medical facilities.
Code information
Lot: 5/31/17 0202 5-81862S, BUD 7/30/17
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0117-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026